METROPOLITAN LIFE INSURANCE CO/NY - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 104 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q3 2018. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q1 2021$237,113
-15.3%
24,048
-6.9%
0.00%0.0%
Q4 2020$279,932
+5.2%
25,8240.0%0.00%
-20.0%
Q3 2020$265,987
-43.4%
25,824
+14.7%
0.01%
-37.5%
Q2 2020$470,113
+141.9%
22,515
+13.2%
0.01%
+100.0%
Q1 2020$194,325
+14.5%
19,890
+35.0%
0.00%
+33.3%
Q4 2019$169,747
+50.8%
14,735
-28.7%
0.00%
+50.0%
Q3 2019$112,553
-54.2%
20,6520.0%0.00%
-50.0%
Q2 2019$245,552
+126.9%
20,6520.0%0.00%
+100.0%
Q1 2019$108,216
-10.6%
20,652
+3.2%
0.00%0.0%
Q3 2018$121,091
-99.9%
20,0150.0%0.00%0.0%
Q2 2018$106,080,00020,0150.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q3 2018
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 4,109,867$42,332,00029.76%
Versant Venture Management, LLC 7,003,892$72,140,00013.20%
Ghost Tree Capital, LLC 1,161,375$11,962,0003.46%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$4,944,0002.54%
Soleus Capital Management, L.P. 364,349$3,753,0001.99%
RTW INVESTMENTS, LP 7,234,764$74,518,0001.79%
RA Capital Management 9,410,860$96,932,0001.77%
FRAZIER MANAGEMENT LLC 1,437,028$14,801,0001.33%
Casdin Capital, LLC 2,750,000$28,325,0001.27%
Avoro Capital Advisors LLC 8,000,000$82,400,0001.17%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders